Spruce Biosciences

#ICYMI: In a recent episode of the CAH Pulse podcast, hosts Stephanie and Dina speak with Lydia, who shares the story of her diagnosis and how her #CAH journey changed with the CARES Foundation, Inc.    Listen to Lydia’s story as she helps others with CAH so that they know that they can live typical, full lives filled with milestones, hope, and, most of all, love as she does. Full episode here: https://lnkd.in/gHFhSVSa  

To all families, medical professionals and loved ones who care for pediatric CAH patients: thank you. Your compassion, resilience, and selflessness are the backbone of your child’s health journey. This National Family Caregivers Month, we celebrate you.    Caregivers are true pillars of strength, providing love, guidance, and around-the-clock support that makes an immeasurable difference in their child’s life. Thank you for your continued efforts to provide for, care, and love pediatric patients.     #NationalFamilyCaregiversMonth #CAH 

Today, we announced our third quarter 2024 financial results and corporate updates. See the full #earnings release to learn more about our latest company highlights and upcoming milestones: https://lnkd.in/eXc4pWPs

Dr. Jung Hee Kim: Shaping the Future of Rare Disease Treatment   Meet Dr. Jung Hee Kim, whose commitment to research and education not only advances treatment for CAH but also aims to improve overall patient care in complex endocrinology areas. With over 3,200 citations to date, Dr. Kim’s extensive research focuses on neuroendocrinology, adrenal gland diseases, and bone metabolic disorders. Bridging the gap between research and #clinical practice in Congenital Adrenal Hyperplasia (#CAH), Dr. Kim is making a lasting impact on the care of patients with CAH and other adrenal gland diseases.    Dr. Kim is an active member of the Korean Endocrine Society, serving on multiple committees, and currently holding the roles of Vice-Secretary General of the Adrenal Gland-Endocrine Hypertension Study Group and Chair of the Research Committee of the Korean Adrenal Study Group. Her innovative approaches to address complex #endocrine disorders are helping advance CAH treatments and improving overall patient care.    Dr. Kim’s extensive work brings hope to families affected by these complex conditions, helping shape the future of rare disease treatment.    #Changemaker 

Happy Halloween and Diwali from Spruce Bio!    We’re happy to gather in our San Francisco office today, where we celebrated with a friendly costume contest and catered lunch. Thank you to our team for bringing your enthusiasm and good spirits to the table!   #Halloween #Diwali

Attending the Guggenheim Securities Healthcare Innovation Conference? Connect with our CEO, Javier Szwarcberg, and tune in to our webcast. More details about our participation here: https://lnkd.in/ezj76rjv

The ability to offer work flexibility is a core part of our culture. Ivona Zielinska, Senior Clinical Trial Manager, shares how Spruce empowers employees to balance their work and well-being so they can be their most productive and fulfilled selves. #LifeAtSpruce

We are committed to meaningfully changing the lives of patients with #endocrine disorders, such as classic Congenital Adrenal Hyperplasia (#CAH). Maralisa Vanandel (Mara), Senior Director, Patient Engagement & Advocacy, shares the importance of considering quality of life metrics in #clinical trials.

We prioritize the mental health of those we serve, including our very own team, providing a workplace that supports and uplifts employee wellness. We pride ourselves on our culture of wellness, which was recently ranked #7 by the San Francisco Business Times and Silicon Valley Business Journal as part of this year’s Best Places to Work in the Bay Area award.  #WorldMentalHealthDay

Dr. Tânia Bachega: Champion for CAH Newborn Screening   Meet Dr. Tania Bachega, a leading advocate for Congenital Adrenal Hyperplasia (#CAH) testing in Brazil. Through her efforts, CAH testing was successfully implemented in the Brazilian Newborn Screening Program, helping countless newborns and families receive an early diagnosis. Understanding the need for patient support within the CAH community, Dr. Bachega played a pivotal role as a scientific consultant in helping two of her patients establish the Brazilian Addisonian Association. This nonprofit now supports over 2,000 members, providing essential resources for patients and families affected by adrenal insufficiency across Brazil. In addition to her groundbreaking research, Dr. Bachega recently secured a parliamentary amendment to increase the production of hydrocortisone—a life-saving medication for CAH patients—at the Hospital das Clínicas. Her dedication to advancing CAH research and patient care has earned her a prestigious award from the I-CAH Registry, recognizing her contributions to improving global knowledge and clinical care. Most recently, she was awarded the highest honor from SLEP (Latin American Society of Pediatric Endocrinology), acknowledging the significant public health impact of her work in CAH.